|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of ABCC4 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
decreases expression multiple interactions |
EXP ISO |
andrographolide results in decreased expression of ACTA2 mRNA; andrographolide results in decreased expression of ACTA2 protein andrographolide inhibits the reaction [Acetaminophen results in increased expression of ACTA2 mRNA]; andrographolide inhibits the reaction [Acetaminophen results in increased expression of ACTA2 protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of ACTA2 protein]; NFE2L2 gene mutant form inhibits the reaction [andrographolide inhibits the reaction [Acetaminophen results in increased expression of ACTA2 protein]] andrographolide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of ACTA2 mRNA]; andrographolide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of ACTA2 protein]; andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of ACTA2 protein]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of ACTA2 protein]] andrographolide inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein] |
CTD |
PMID:29355602 PMID:31128153 PMID:31706003 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of ADH7 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 2:226,748,724...226,763,183
Ensembl chr 2:226,741,788...226,763,182
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of ANKRD1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
|
|
G |
Atf2 |
activating transcription factor 2 |
multiple interactions |
ISO |
andrographolide inhibits the reaction [cobaltous chloride results in increased expression of ATF2 protein modified form]; DUSP10 protein promotes the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of ATF2 protein modified form]] |
CTD |
PMID:29165873 |
|
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
|
|
G |
B4galt1 |
beta-1,4-galactosyltransferase 1 |
increases expression |
ISO |
andrographolide results in increased expression of B4GALT1 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 5:55,935,614...55,982,461
Ensembl chr 5:55,935,615...55,982,461
|
|
G |
Bad |
BCL2-associated agonist of cell death |
increases expression |
ISO |
andrographolide results in increased expression of BAD protein |
CTD |
PMID:35917943 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
affects folding multiple interactions increases expression |
ISO |
andrographolide affects the folding of BAX protein [andrographolide co-treated with Cisplatin] results in increased expression of BAX mRNA; andrographolide promotes the reaction [Cisplatin results in increased expression of BAX protein]; Fluorouracil promotes the reaction [andrographolide affects the folding of BAX protein] andrographolide results in increased expression of BAX mRNA; andrographolide results in increased expression of BAX protein |
CTD |
PMID:19097688 PMID:23845849 PMID:24563380 PMID:35917943 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
increases expression |
ISO |
andrographolide results in increased expression of BBC3 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO |
andrographolide results in decreased expression of BCL2 protein [andrographolide co-treated with Cisplatin] results in decreased expression of BCL2 mRNA |
CTD |
PMID:23845849 PMID:24563380 PMID:35917943 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of BHMT mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
|
|
G |
Bid |
BH3 interacting domain death agonist |
multiple interactions increases expression |
EXP ISO |
andrographolide inhibits the reaction [Copper Sulfate results in decreased expression of and results in increased cleavage of BID protein]; andrographolide promotes the reaction [Penicillamine inhibits the reaction [Copper Sulfate results in decreased expression of and results in increased cleavage of BID protein]]; Penicillamine promotes the reaction [andrographolide inhibits the reaction [Copper Sulfate results in decreased expression of and results in increased cleavage of BID protein]] andrographolide results in increased expression of BID mRNA; andrographolide results in increased expression of BID protein [andrographolide co-treated with Cisplatin] results in increased expression of BID mRNA |
CTD |
PMID:20946909 PMID:24563380 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
increases expression multiple interactions |
ISO |
andrographolide results in increased expression of BIRC3 mRNA [andrographolide co-treated with TNF protein] results in decreased expression of BIRC3 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
andrographolide results in decreased expression of BIRC5 protein |
CTD |
PMID:23845849 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Blvrb |
biliverdin reductase B |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of BLVRB mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions increases expression increases cleavage |
ISO EXP |
andrographolide results in increased activity of CASP3 protein andrographolide inhibits the reaction [Copper Sulfate results in increased cleavage of CASP3 protein]; andrographolide promotes the reaction [Penicillamine inhibits the reaction [Copper Sulfate results in increased cleavage of CASP3 protein]]; Penicillamine promotes the reaction [andrographolide inhibits the reaction [Copper Sulfate results in increased cleavage of CASP3 protein]] [andrographolide co-treated with Cisplatin] results in increased expression of CASP3 mRNA; CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP3 protein]]; Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP3 protein] andrographolide results in increased expression of CASP3 mRNA andrographolide inhibits the reaction [TGFB1 protein results in decreased cleavage of CASP3 protein] andrographolide results in increased cleavage of CASP3 protein |
CTD |
PMID:19097688 PMID:20946909 PMID:24563380 PMID:31706003 PMID:35917943 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases activity multiple interactions increases expression |
ISO EXP |
andrographolide results in increased activity of CASP8 protein andrographolide inhibits the reaction [Copper Sulfate results in increased activity of CASP8 protein] [andrographolide co-treated with Cisplatin] results in increased expression of CASP8 mRNA; CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP3 protein]]; CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP9 protein]]; CASP8 results in increased susceptibility to [andrographolide co-treated with Fluorouracil]; Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP8 protein] andrographolide results in increased expression of CASP8 mRNA |
CTD |
PMID:19097688 PMID:20946909 PMID:24563380 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases activity multiple interactions increases expression |
ISO EXP |
andrographolide results in increased activity of CASP9 protein [andrographolide co-treated with Cisplatin] results in increased expression of CASP9 mRNA; CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP9 protein]]; Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP9 protein] andrographolide inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein]; andrographolide promotes the reaction [Penicillamine inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein]]; Penicillamine promotes the reaction [andrographolide inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein]] andrographolide results in increased expression of CASP9 mRNA |
CTD |
PMID:19097688 PMID:20946909 PMID:24563380 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
ISO EXP |
[andrographolide co-treated with Polylactic Acid-Polyglycolic Acid Copolymer] inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]; andrographolide inhibits the reaction [sodium arsenite results in decreased activity of CAT protein] andrographolide inhibits the reaction [Freund's Adjuvant results in decreased activity of CAT protein] |
CTD |
PMID:26485141 PMID:32061742 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbr1 |
carbonyl reductase 1 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CBR1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G |
Cbr3 |
carbonyl reductase 3 |
multiple interactions increases expression |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CBR3 mRNA andrographolide results in increased expression of CBR3 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr11:33,008,615...33,016,877
Ensembl chr11:33,008,615...33,016,875
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions increases expression |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CCL2 mRNA andrographolide results in increased expression of CCL2 mRNA |
CTD |
PMID:19737545 PMID:35724838 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
increases expression |
ISO |
andrographolide results in increased expression of CCL20 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccn2 |
cellular communication network factor 2 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CCN2 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccna2 |
cyclin A2 |
multiple interactions decreases expression |
ISO |
andrographolide inhibits the reaction [CCNA2 protein binds to CDK2 protein] andrographolide results in decreased expression of CCNA2 protein |
CTD |
PMID:18619950 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions decreases expression |
ISO |
andrographolide inhibits the reaction [CCND1 protein binds to CDK4 protein] andrographolide results in decreased expression of CCND1 protein |
CTD |
PMID:18619950 PMID:23845849 PMID:35917943 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression multiple interactions |
ISO |
andrographolide results in decreased expression of CCNE1 protein andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCNE1 protein] |
CTD |
PMID:23845849 PMID:27475717 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions increases expression |
ISO |
andrographolide inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of CDH1 protein] andrographolide inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of CDH1 protein]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of CDH1 protein]] andrographolide results in increased expression of CDH1 protein |
CTD |
PMID:31128153 PMID:35917943 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh17 |
cadherin 17 |
decreases expression multiple interactions |
ISO |
andrographolide results in decreased expression of CDH17 mRNA [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CDH17 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 5:25,262,820...25,314,884
Ensembl chr 5:25,262,758...25,314,884
|
|
G |
Cdh2 |
cadherin 2 |
multiple interactions decreases expression |
ISO |
andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CDH2 protein] andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CDH2 protein]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CDH2 protein]] andrographolide results in decreased expression of CDH2 protein |
CTD |
PMID:31128153 PMID:35917943 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression multiple interactions |
ISO |
andrographolide results in decreased expression of CDK2 protein andrographolide inhibits the reaction [CCNA2 protein binds to CDK2 protein] andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CDK2 protein] |
CTD |
PMID:18619950 PMID:27475717 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
multiple interactions decreases expression |
ISO |
andrographolide inhibits the reaction [CCND1 protein binds to CDK4 protein] andrographolide results in decreased expression of CDK4 protein |
CTD |
PMID:18619950 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
andrographolide results in increased expression of CDKN1A protein |
CTD |
PMID:18619950 PMID:23845849 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
multiple interactions |
ISO |
andrographolide affects the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] affects the expression of CEBPA mRNA]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein] |
CTD |
PMID:27475717 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions |
ISO |
andrographolide affects the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] affects the expression of CEBPB mRNA]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of and results in increased phosphorylation of CEBPB protein] |
CTD |
PMID:27475717 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Ces3a |
carboxylesterase 3a |
multiple interactions increases expression |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CES3 mRNA andrographolide results in increased expression of CES3 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr19:32,992,386...33,000,562
|
|
G |
Cish |
cytokine inducible SH2-containing protein |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CISH mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
|
|
G |
Cnn2 |
calponin 2 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CNN2 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 7:9,712,505...9,719,678
Ensembl chr 7:9,712,516...9,719,656
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions decreases expression |
ISO EXP |
andrographolide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of COL1A1 mRNA] andrographolide results in decreased expression of COL1A1 mRNA andrographolide inhibits the reaction [Acetaminophen results in increased expression of COL1A1 mRNA]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA] |
CTD |
PMID:29355602 PMID:31706003 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
decreases expression multiple interactions |
ISO EXP |
andrographolide results in decreased expression of COL1A2 mRNA andrographolide inhibits the reaction [Acetaminophen results in increased expression of COL1A2 mRNA] |
CTD |
PMID:29355602 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
decreases expression multiple interactions |
EXP ISO |
andrographolide results in decreased expression of COL3A1 mRNA andrographolide inhibits the reaction [Acetaminophen results in increased expression of COL3A1 mRNA]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 mRNA]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 protein] andrographolide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of COL3A1 mRNA] |
CTD |
PMID:29355602 PMID:31706003 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Crct1 |
cysteine-rich C-terminal 1 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CRCT1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 2:178,633,789...178,635,274
Ensembl chr 2:178,634,092...178,634,394
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions decreases expression |
ISO |
KYA1797K promotes the reaction [andrographolide results in decreased expression of CTNNB1 protein] |
CTD |
PMID:35917943 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
multiple interactions increases expression |
ISO |
[andrographolide co-treated with TNF protein] results in decreased expression of CXCL1 mRNA andrographolide results in increased expression of CXCL1 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl13 |
C-X-C motif chemokine ligand 13 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CXCL13 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr14:13,608,894...13,613,965
Ensembl chr14:13,608,902...13,613,933
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions increases expression |
EXP ISO |
andrographolide inhibits the reaction [Freund's Adjuvant results in increased expression of CXCL2 protein] andrographolide results in increased expression of CXCL2 mRNA |
CTD |
PMID:32061742 PMID:35724838 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions increases expression |
ISO |
[andrographolide co-treated with TNF protein] results in decreased expression of CXCL1 mRNA andrographolide results in increased expression of CXCL1 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases activity increases expression |
ISO |
[andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1A1 mRNA; [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP1A1 mRNA; [andrographolide co-treated with Tetrachlorodibenzodioxin] results in increased expression of CYP1A1 mRNA; Acetylcysteine affects the reaction [andrographolide affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]]; andrographolide affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; andrographolide promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Ascorbic Acid affects the reaction [andrographolide affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]]; beta-Naphthoflavone promotes the reaction [andrographolide results in increased expression of CYP1A1 mRNA]; Buthionine Sulfoximine promotes the reaction [andrographolide affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]]; Glutathione affects the reaction [andrographolide affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]]; Hydrogen Peroxide promotes the reaction [andrographolide affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]]; resveratrol inhibits the reaction [[andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1A1 mRNA] andrographolide results in increased activity of CYP1A1 protein |
CTD |
PMID:17825862 PMID:19737545 PMID:21094198 PMID:21963808 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases expression multiple interactions increases expression |
ISO EXP |
andrographolide results in decreased expression of CYP1A2 mRNA [andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1A2 mRNA; [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 mRNA andrographolide results in increased expression of CYP1A2 mRNA andrographolide affects the reaction [CYP1A2 protein results in increased metabolism of Theophylline] |
CTD |
PMID:17825862 PMID:19041297 PMID:19737545 PMID:20096675 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions |
ISO |
[andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1B1 mRNA; andrographolide promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1B1 mRNA] |
CTD |
PMID:17825862 PMID:19737545 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
increases expression multiple interactions |
ISO |
andrographolide results in increased expression of CYP2A4 mRNA beta-Naphthoflavone promotes the reaction [andrographolide results in increased expression of CYP2A4 mRNA] |
CTD |
PMID:19737545 |
|
NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases activity multiple interactions increases expression |
ISO |
andrographolide results in increased activity of CYP2B10 protein [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP2B10 mRNA andrographolide results in increased expression of CYP2B10 mRNA |
CTD |
PMID:19737545 PMID:21094198 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
decreases expression |
EXP |
andrographolide results in decreased expression of CYP2C11 mRNA; andrographolide results in decreased expression of CYP2C11 protein |
CTD |
PMID:19041297 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases expression |
ISO |
andrographolide results in decreased expression of CYP3A4 mRNA |
CTD |
PMID:19041297 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
decreases expression |
EXP |
andrographolide results in decreased expression of CYP3A23-3A1 mRNA |
CTD |
PMID:19041297 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
increases expression |
ISO |
andrographolide results in increased expression of CYP8B1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
|
|
G |
Ddc |
dopa decarboxylase |
multiple interactions increases expression |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of DDC mRNA andrographolide results in increased expression of DDC mRNA |
CTD |
PMID:19737545 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
andrographolide results in increased expression of DDIT3 protein |
CTD |
PMID:35724838 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dusp10 |
dual specificity phosphatase 10 |
increases expression multiple interactions |
ISO |
andrographolide results in increased expression of DUSP10 mRNA; andrographolide results in increased expression of DUSP10 protein 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [andrographolide results in increased expression of DUSP10 mRNA]; 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [andrographolide results in increased expression of DUSP10 protein]; DUSP10 protein promotes the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of ATF2 protein modified form]]; DUSP10 protein promotes the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mRNA]]; HMOX1 protein promotes the reaction [andrographolide results in increased expression of DUSP10 protein]; zinc protoporphyrin inhibits the reaction [andrographolide results in increased expression of DUSP10 mRNA]; zinc protoporphyrin inhibits the reaction [andrographolide results in increased expression of DUSP10 protein] |
CTD |
PMID:29165873 |
|
NCBI chr13:95,613,716...95,651,716
Ensembl chr13:95,614,292...95,651,716
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions increases expression |
ISO |
andrographolide inhibits the reaction [cobaltous chloride results in increased expression of EDN1 mRNA]; andrographolide inhibits the reaction [cobaltous chloride results in increased expression of EDN1 protein]; Vanadates inhibits the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of EDN1 mRNA]]; Vanadates inhibits the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of EDN1 protein]] andrographolide results in increased expression of EDN1 mRNA |
CTD |
PMID:27297870 PMID:29165873 PMID:35724838 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
multiple interactions increases expression |
ISO |
EGLN1 mutant form inhibits the reaction [andrographolide results in decreased expression of HIF1A protein]; EGLN1 mutant form inhibits the reaction [andrographolide results in decreased expression of VEGFA protein]; TGFB1 protein inhibits the reaction [andrographolide results in increased expression of EGLN1 mRNA]; TGFB1 protein inhibits the reaction [andrographolide results in increased expression of EGLN1 protein] andrographolide results in increased expression of EGLN1 mRNA; andrographolide results in increased expression of EGLN1 protein |
CTD |
PMID:21134392 PMID:27297870 |
|
NCBI chr19:52,867,900...52,907,308
Ensembl chr19:52,869,486...52,907,777
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
increases expression |
ISO |
andrographolide results in increased expression of EGLN3 protein |
CTD |
PMID:27297870 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Eid3 |
EP300 interacting inhibitor of differentiation 3 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of EID3 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 7:20,860,073...20,861,395
|
|
G |
Elane |
elastase, neutrophil expressed |
multiple interactions |
EXP |
andrographolide inhibits the reaction [Freund's Adjuvant results in increased expression of ELANE protein] |
CTD |
PMID:32061742 |
|
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
multiple interactions |
ISO |
andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of EZH2 protein]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of EZH2 protein]] |
CTD |
PMID:31128153 |
|
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions increases expression |
ISO |
[andrographolide co-treated with Cisplatin] promotes the reaction [FAS protein binds to FASLG protein]; [andrographolide co-treated with Cisplatin] results in increased expression of FAS mRNA; [andrographolide co-treated with Cisplatin] results in increased expression of FAS protein; andrographolide promotes the reaction [FAS protein binds to FASLG protein] andrographolide results in increased expression of FAS mRNA; andrographolide results in increased expression of FAS protein |
CTD |
PMID:24563380 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
multiple interactions increases expression |
ISO |
[andrographolide co-treated with Cisplatin] promotes the reaction [FAS protein binds to FASLG protein]; [andrographolide co-treated with Cisplatin] results in increased expression of FASLG mRNA; [andrographolide co-treated with Cisplatin] results in increased expression of FASLG protein; andrographolide promotes the reaction [FAS protein binds to FASLG protein] andrographolide results in increased expression of FASLG mRNA; andrographolide results in increased expression of FASLG protein |
CTD |
PMID:24563380 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fasn |
fatty acid synthase |
multiple interactions |
ISO |
andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FASN mRNA]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FASN protein] |
CTD |
PMID:27475717 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
decreases expression |
ISO |
andrographolide results in decreased expression of FLT1 mRNA |
CTD |
PMID:28651835 |
|
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
ISO |
andrographolide inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein] |
CTD |
PMID:31706003 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
andrographolide results in decreased localization of and results in decreased activity of FOS protein |
CTD |
PMID:19426720 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression multiple interactions decreases expression |
EXP ISO |
andrographolide results in increased expression of GCLC mRNA; andrographolide results in increased expression of GCLC protein andrographolide inhibits the reaction [Acetaminophen results in decreased expression of GCLC mRNA] andrographolide results in decreased expression of GCLC mRNA [andrographolide co-treated with TNF protein] results in increased expression of GCLC mRNA |
CTD |
PMID:25110055 PMID:29355602 PMID:35724838 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
multiple interactions increases expression decreases expression |
ISO EXP |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GCLM mRNA; andrographolide inhibits the reaction [Acetaminophen results in decreased expression of GCLM mRNA] andrographolide results in increased expression of GCLM mRNA; andrographolide results in increased expression of GCLM protein andrographolide results in decreased expression of GCLM mRNA [andrographolide co-treated with TNF protein] results in increased expression of GCLM mRNA |
CTD |
PMID:19737545 PMID:25110055 PMID:29355602 PMID:35724838 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
[polylactic acid-polyglycolic acid copolymer co-treated with andrographolide] inhibits the reaction [sodium arsenite results in increased activity of GPT protein] |
CTD |
PMID:26485141 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions decreases phosphorylation |
ISO |
andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of GSK3B protein] andrographolide results in decreased phosphorylation of GSK3B protein |
CTD |
PMID:27475717 PMID:35917943 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases activity |
EXP |
andrographolide results in increased activity of GSR protein |
CTD |
PMID:25110055 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GSTM2 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstm4 |
glutathione S-transferase mu 4 |
increases expression multiple interactions |
ISO |
andrographolide results in increased expression of GSTM4 mRNA [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GSTM4 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
increases expression multiple interactions |
ISO |
andrographolide results in increased expression of GSTM3 mRNA [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GSTM3 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
|
|
G |
Hdac1 |
histone deacetylase 1 |
decreases expression |
ISO |
andrographolide results in decreased expression of HDAC1 protein |
CTD |
PMID:28651835 |
|
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions increases expression decreases expression |
ISO |
[andrographolide co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] results in increased ubiquitination of HIF1A protein; [andrographolide co-treated with cobaltous chloride] results in increased hydroxylation of HIF1A protein; andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mRNA]; andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A protein]; andrographolide inhibits the reaction [HIF1A protein binds to VEGFA promoter]; andrographolide results in decreased expression of and affects the localization of HIF1A protein; andrographolide results in decreased expression of and results in increased degradation of HIF1A protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [andrographolide results in decreased expression of HIF1A protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [andrographolide results in increased degradation of HIF1A protein]; DUSP10 protein promotes the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mRNA]]; EGLN1 mutant form inhibits the reaction [andrographolide results in decreased expression of HIF1A protein]; HMOX1 protein affects the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mRNA]]; NFE2L2 protein affects the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mRNA]]; pyrazolanthrone inhibits the reaction [andrographolide results in decreased expression of HIF1A protein]; Vanadates inhibits the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mRNA]]; Vanadates inhibits the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A protein]] andrographolide results in increased expression of HIF1A protein modified form |
CTD |
PMID:21134392 PMID:27297870 PMID:28651835 PMID:29165873 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions decreases expression |
EXP ISO |
andrographolide results in increased expression of HMOX1 mRNA; andrographolide results in increased expression of HMOX1 protein [andrographolide co-treated with TNF protein] results in increased expression of HMOX1 mRNA; HMOX1 protein affects the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mRNA]]; HMOX1 protein promotes the reaction [andrographolide results in increased expression of DUSP10 protein] andrographolide inhibits the reaction [Acetaminophen results in decreased expression of HMOX1 mRNA] andrographolide results in decreased expression of HMOX1 mRNA |
CTD |
PMID:25110055 PMID:27297870 PMID:29165873 PMID:29355602 PMID:35724838 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hp |
haptoglobin |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of HP mRNA |
CTD |
PMID:19737545 |
|
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Hpgd |
15-hydroxyprostaglandin dehydrogenase |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of HPGD mRNA |
CTD |
PMID:19737545 |
|
NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
[andrographolide co-treated with TNF protein] results in decreased expression of ICAM1 mRNA; andrographolide inhibits the reaction [IL1B protein results in increased expression of ICAM1 protein]; andrographolide inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] |
CTD |
PMID:35724838 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ikbke |
inhibitor of nuclear factor kappa B kinase subunit epsilon |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of IKBKE mRNA |
CTD |
PMID:19737545 |
|
NCBI chr13:42,712,154...42,738,470
Ensembl chr13:42,712,159...42,737,143
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
andrographolide inhibits the reaction [IL1B protein affects the localization of NFKBIA protein]; andrographolide inhibits the reaction [IL1B protein affects the localization of RELA protein]; andrographolide inhibits the reaction [IL1B protein results in increased expression of ICAM1 protein]; andrographolide inhibits the reaction [IL1B protein results in increased expression of TNFAIP3 protein] |
CTD |
PMID:35724838 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
EXP |
andrographolide inhibits the reaction [Lipopolysaccharides results in increased expression of IL2 protein] |
CTD |
PMID:38229310 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO EXP |
andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased secretion of IL6 protein]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of CDH1 protein]]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of ACTA2 protein]]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CDH2 protein]]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of EZH2 protein]]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of HOTAIR mRNA]]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of VIM protein]]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased phosphorylation of STAT3 protein]]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased secretion of IL6 protein]] andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of IL6 mRNA]; andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased secretion of IL6 protein] andrographolide inhibits the reaction [Freund's Adjuvant results in increased expression of IL6 protein]; andrographolide inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] |
CTD |
PMID:31128153 PMID:32061742 PMID:38229310 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
ISO |
andrographolide affects the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] affects the expression of CEBPA mRNA]; andrographolide affects the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] affects the expression of CEBPB mRNA]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of and results in increased phosphorylation of CEBPB protein]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCNE1 protein]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CDK2 protein]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FASN mRNA]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FASN protein]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of SCD1 mRNA]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of SCD1 protein]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of GSK3B protein]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of MAPK1 protein]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:27475717 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
andrographolide results in decreased localization of and results in decreased activity of JUN protein |
CTD |
PMID:19426720 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kdr |
kinase insert domain receptor |
multiple interactions decreases expression |
ISO |
[andrographolide co-treated with KDR protein] inhibits the reaction [VEGFA protein binds to KDR protein]; andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of KDR protein] andrographolide results in decreased expression of KDR mRNA |
CTD |
PMID:24814888 PMID:28651835 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
decreases expression |
ISO |
andrographolide results in decreased expression of KEAP1 mRNA; andrographolide results in decreased expression of KEAP1 protein |
CTD |
PMID:29355602 PMID:35724838 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Krt5 |
keratin 5 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of KRT5 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 7:132,846,132...132,851,861
Ensembl chr 7:132,846,136...132,851,850
|
|
G |
Mafg |
MAF bZIP transcription factor G |
decreases expression |
ISO |
andrographolide results in decreased expression of MAFG mRNA |
CTD |
PMID:35724838 |
|
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
|
|
G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
multiple interactions |
ISO |
andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP2K4 protein] |
CTD |
PMID:24814888 |
|
NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
|
|
G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
multiple interactions |
ISO |
andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP2K6 protein] |
CTD |
PMID:24814888 |
|
NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
|
|
G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
multiple interactions |
ISO |
andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP2K7 protein] |
CTD |
PMID:24814888 |
|
NCBI chr12:2,591,312...2,600,534
Ensembl chr12:2,591,219...2,604,222
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
multiple interactions |
ISO |
andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP3K5 protein] |
CTD |
PMID:24814888 |
|
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAPK1 protein] andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of MAPK1 protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:24814888 PMID:27475717 PMID:31706003 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAPK3 protein] andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of MAPK3 protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:24814888 PMID:27475717 PMID:31706003 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions decreases expression |
ISO |
andrographolide inhibits the reaction [TGFB1 protein results in increased expression of MMP2 mRNA] andrographolide results in decreased expression of MMP2 protein |
CTD |
PMID:31706003 PMID:35917943 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
decreases expression multiple interactions |
ISO |
andrographolide results in decreased expression of MMP7 mRNA; andrographolide results in decreased expression of MMP7 protein andrographolide results in decreased expression of and results in decreased activity of MMP7 protein |
CTD |
PMID:19426720 PMID:35917943 |
|
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
ISO |
andrographolide inhibits the reaction [TGFB1 protein results in increased expression of MMP9 mRNA] andrographolide results in decreased expression of MMP9 protein |
CTD |
PMID:31706003 PMID:35917943 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
andrographolide inhibits the reaction [Freund's Adjuvant results in increased expression of MPO protein] |
CTD |
PMID:32061742 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mta1 |
metastasis associated 1 |
decreases expression |
ISO |
andrographolide results in decreased expression of MTA1 mRNA; andrographolide results in decreased expression of MTA1 protein |
CTD |
PMID:28651835 |
|
NCBI chr 6:132,178,608...132,217,641
Ensembl chr 6:132,178,853...132,217,641
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression |
ISO |
andrographolide results in decreased expression of MYC protein |
CTD |
PMID:35917943 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myo18b |
myosin XVIIIb |
decreases expression |
ISO |
andrographolide results in decreased expression of MYO18B mRNA |
CTD |
PMID:19737545 |
|
NCBI chr12:43,747,003...43,953,694
Ensembl chr12:43,747,010...43,953,695
|
|
G |
Necab1 |
N-terminal EF-hand calcium binding protein 1 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of NECAB1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 5:28,357,859...28,578,642
Ensembl chr 5:28,357,859...28,578,642 Ensembl chr 5:28,357,859...28,578,642
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases activity multiple interactions decreases response to substance |
EXP ISO |
andrographolide results in increased activity of NFE2L2 protein andrographolide results in increased expression of and affects the localization of NFE2L2 protein; NFE2L2 protein affects the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mRNA]] NFE2L2 gene mutant form inhibits the reaction [andrographolide inhibits the reaction [Acetaminophen results in increased expression of ACTA2 protein]] NFE2L2 gene mutant form results in decreased susceptibility to andrographolide |
CTD |
PMID:25110055 PMID:27297870 PMID:29355602 PMID:35724838 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
andrographolide inhibits the reaction [IL1B protein affects the localization of NFKBIA protein]; andrographolide inhibits the reaction [TNF protein affects the localization of NFKBIA protein] |
CTD |
PMID:35724838 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nfkbie |
NFKB inhibitor epsilon |
increases expression |
ISO |
andrographolide results in increased expression of NFKBIE mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 9:15,443,600...15,450,437
Ensembl chr 9:15,436,941...15,450,437
|
|
G |
Ngb |
neuroglobin |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of NGB mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 6:106,744,378...106,749,830
Ensembl chr 6:106,744,378...106,749,830
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
EXP |
andrographolide inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] |
CTD |
PMID:38229310 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions |
EXP |
andrographolide inhibits the reaction [Lipopolysaccharides results in decreased activity of NOS3 protein] |
CTD |
PMID:38229310 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression multiple interactions decreases expression |
ISO EXP |
andrographolide results in increased expression of NQO1 mRNA [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of NQO1 mRNA; andrographolide promotes the reaction [Acetaminophen results in increased expression of NQO1 mRNA] andrographolide results in increased expression of NQO1 protein andrographolide results in decreased expression of NQO1 mRNA |
CTD |
PMID:19737545 PMID:29355602 PMID:35724838 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Olr1 |
oxidized low density lipoprotein receptor 1 |
increases expression |
ISO |
andrographolide results in increased expression of OLR1 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 4:162,926,436...162,949,057
Ensembl chr 4:162,926,439...162,948,523
|
|
G |
OR6c8 |
olfactory receptor family 6 subfamily C member 8 |
decreases expression |
ISO |
andrographolide results in decreased expression of OR6C8 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 7:1,502,160...1,503,089
Ensembl chr 7:1,501,940...1,507,336
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage |
ISO |
andrographolide results in increased cleavage of PARP1 protein |
CTD |
PMID:35917943 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions decreases expression |
ISO |
andrographolide inhibits the reaction [TGFB1 protein results in increased expression of PCNA protein] andrographolide results in decreased expression of PCNA protein |
CTD |
PMID:31706003 PMID:35917943 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
increases expression |
ISO |
andrographolide results in increased expression of PDGFB mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pdzrn3 |
PDZ domain containing RING finger 3 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of PDZRN3 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 4:133,770,736...133,996,959
Ensembl chr 4:133,770,736...133,996,959
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
decreases expression |
ISO |
andrographolide results in decreased expression of PECAM1 protein |
CTD |
PMID:28651835 |
|
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
|
|
G |
Phospho1 |
phosphoethanolamine/phosphocholine phosphatase 1 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of PHOSPHO1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr10:80,762,062...80,769,596
Ensembl chr10:80,760,792...80,770,342
|
|
G |
Plau |
plasminogen activator, urokinase |
increases expression |
ISO |
andrographolide results in increased expression of PLAU mRNA |
CTD |
PMID:35724838 |
|
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Plscr1 |
phospholipid scramblase 1 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of PLSCR1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 8:92,784,279...92,804,698
Ensembl chr 8:92,784,356...92,804,692
|
|
G |
Por |
cytochrome p450 oxidoreductase |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of POR mRNA |
CTD |
PMID:19737545 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein] |
CTD |
PMID:27475717 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prkag2 |
protein kinase AMP-activated non-catalytic subunit gamma 2 |
increases expression |
ISO |
andrographolide results in increased expression of PRKAG2 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 4:10,010,890...10,252,155
Ensembl chr 4:10,010,890...10,252,142
|
|
G |
Ptgr1 |
prostaglandin reductase 1 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of PTGR1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
multiple interactions |
ISO |
andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of RAF1 protein] |
CTD |
PMID:24814888 |
|
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases phosphorylation |
ISO |
andrographolide results in decreased phosphorylation of RB1 protein |
CTD |
PMID:18619950 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
andrographolide inhibits the reaction [IL1B protein affects the localization of RELA protein]; andrographolide inhibits the reaction [TNF protein affects the localization of RELA protein]; andrographolide results in decreased expression of and results in decreased localization of RELA protein; pyrrolidine dithiocarbamic acid promotes the reaction [andrographolide results in decreased expression of and results in decreased localization of RELA protein] |
CTD |
PMID:35724838 PMID:35917943 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
S100a4 |
S100 calcium-binding protein A4 |
multiple interactions |
EXP |
andrographolide inhibits the reaction [Bleomycin results in increased expression of S100A4 protein] |
CTD |
PMID:31706003 |
|
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
|
|
G |
Scd |
stearoyl-CoA desaturase |
multiple interactions |
ISO |
andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of SCD1 mRNA]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of SCD1 protein] |
CTD |
PMID:27475717 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Serpina7 |
serpin family A member 7 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of SERPINA7 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr X:102,663,242...102,722,319
Ensembl chr X:102,663,405...102,669,040
|
|
G |
Slc1a4 |
solute carrier family 1 member 4 |
multiple interactions increases expression |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of SLC1A4 mRNA andrographolide results in increased expression of SLC1A4 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr14:94,530,801...94,560,190
Ensembl chr14:94,529,084...94,560,418
|
|
G |
Slc3a2 |
solute carrier family 3 member 2 |
decreases expression |
ISO |
andrographolide results in decreased expression of SLC3A2 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
increases expression |
ISO |
andrographolide results in increased expression of SLC7A11 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Smad2 |
SMAD family member 2 |
multiple interactions |
ISO |
andrographolide inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD2 protein] |
CTD |
PMID:31706003 |
|
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
|
|
G |
Smad3 |
SMAD family member 3 |
multiple interactions |
ISO |
andrographolide inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:31706003 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Snai1 |
snail family transcriptional repressor 1 |
decreases expression |
ISO |
andrographolide results in decreased expression of SNAI1 protein |
CTD |
PMID:35917943 |
|
NCBI chr 3:156,248,479...156,252,969
Ensembl chr 3:156,248,485...156,252,969
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases expression |
EXP |
andrographolide results in increased expression of SOD1 mRNA; andrographolide results in increased expression of SOD1 protein |
CTD |
PMID:25110055 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of SPP1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression decreases expression |
ISO |
andrographolide results in increased expression of SQSTM1 protein andrographolide results in decreased expression of SQSTM1 mRNA |
CTD |
PMID:29355602 PMID:35724838 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srxn1 |
sulfiredoxin 1 |
multiple interactions increases expression decreases expression |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of SRXN1 mRNA andrographolide results in increased expression of SRXN1 mRNA andrographolide results in increased expression of SRXN1 protein [andrographolide co-treated with TNF protein] results in increased expression of SRXN1 mRNA andrographolide results in decreased expression of SRXN1 mRNA |
CTD |
PMID:19737545 PMID:35724838 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
decreases activity multiple interactions |
ISO |
andrographolide results in decreased activity of STAT3 protein andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased phosphorylation of STAT3 protein]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased phosphorylation of STAT3 protein]] |
CTD |
PMID:23845849 PMID:31128153 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Steap4 |
STEAP4 metalloreductase |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of STEAP4 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 4:26,077,182...26,099,859
Ensembl chr 4:26,054,671...26,099,859
|
|
G |
Tap1 |
transporter 1, ATP binding cassette subfamily B member |
increases expression |
ISO |
andrographolide results in increased expression of TAP1 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901
|
|
G |
Tdo2 |
tryptophan 2,3-dioxygenase |
multiple interactions increases expression |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of TDO2 mRNA andrographolide results in increased expression of TDO2 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 2:167,269,581...167,287,511
Ensembl chr 2:167,269,579...167,287,511
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases expression multiple interactions |
ISO EXP |
andrographolide results in decreased expression of TGFB1 protein TGFB1 protein inhibits the reaction [andrographolide results in increased expression of EGLN1 mRNA]; TGFB1 protein inhibits the reaction [andrographolide results in increased expression of EGLN1 protein] andrographolide inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein] andrographolide inhibits the reaction [TGFB1 protein results in decreased cleavage of CASP3 protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 mRNA]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of MMP2 mRNA]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of MMP9 mRNA]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of PCNA protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased expression of TIMP1 mRNA]; andrographolide inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK1 protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK3 protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD2 protein]; andrographolide inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:21134392 PMID:31706003 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Thbs1 |
thrombospondin 1 |
multiple interactions decreases expression |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of THBS1 mRNA andrographolide results in decreased expression of THBS1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions |
ISO |
andrographolide inhibits the reaction [TGFB1 protein results in increased expression of TIMP1 mRNA] |
CTD |
PMID:31706003 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tmprss11f |
transmembrane serine protease 11F |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of TMPRSS11F mRNA |
CTD |
PMID:19737545 |
|
NCBI chr14:21,492,896...21,534,792
Ensembl chr14:21,429,418...21,534,809
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP ISO |
andrographolide inhibits the reaction [Copper Sulfate results in increased expression of TNF protein]; andrographolide inhibits the reaction [Freund's Adjuvant results in increased expression of TNF protein]; andrographolide inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] [andrographolide co-treated with TNF protein] results in decreased expression of BIRC3 mRNA; [andrographolide co-treated with TNF protein] results in decreased expression of CXCL1 mRNA; [andrographolide co-treated with TNF protein] results in decreased expression of ICAM1 mRNA; [andrographolide co-treated with TNF protein] results in decreased expression of TNFAIP3 mRNA; [andrographolide co-treated with TNF protein] results in increased expression of GCLC mRNA; [andrographolide co-treated with TNF protein] results in increased expression of GCLM mRNA; [andrographolide co-treated with TNF protein] results in increased expression of HMOX1 mRNA; [andrographolide co-treated with TNF protein] results in increased expression of SRXN1 mRNA; andrographolide inhibits the reaction [TNF protein affects the localization of NFKBIA protein]; andrographolide inhibits the reaction [TNF protein affects the localization of RELA protein]; andrographolide inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; andrographolide inhibits the reaction [TNF protein results in increased expression of TNFAIP3 protein] |
CTD |
PMID:20946909 PMID:32061742 PMID:35724838 PMID:38229310 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
increases expression multiple interactions |
ISO |
andrographolide results in increased expression of TNFAIP3 mRNA; andrographolide results in increased expression of TNFAIP3 protein [andrographolide co-treated with TNF protein] results in decreased expression of TNFAIP3 mRNA; andrographolide inhibits the reaction [IL1B protein results in increased expression of TNFAIP3 protein]; andrographolide inhibits the reaction [TNF protein results in increased expression of TNFAIP3 protein] |
CTD |
PMID:35724838 |
|
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tnfrsf9 |
TNF receptor superfamily member 9 |
increases expression |
ISO |
andrographolide results in increased expression of TNFRSF9 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression |
ISO |
andrographolide results in increased expression of and results in increased phosphorylation of TP53 protein; Fluorouracil promotes the reaction [andrographolide results in increased expression of TP53] |
CTD |
PMID:18619950 PMID:19097688 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
decreases expression |
ISO |
andrographolide results in decreased expression of TRIB3 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
decreases expression |
ISO |
andrographolide results in decreased expression of TXNRD1 mRNA |
CTD |
PMID:35724838 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
multiple interactions increases expression |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of UGT1A6 mRNA andrographolide results in increased expression of UGT1A6 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions increases expression |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of VCAM1 mRNA andrographolide results in increased expression of VCAM1 mRNA |
CTD |
PMID:19737545 PMID:35724838 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions decreases expression |
ISO |
[andrographolide co-treated with KDR protein] inhibits the reaction [VEGFA protein binds to KDR protein]; andrographolide inhibits the reaction [HIF1A protein binds to VEGFA promoter]; andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of KDR protein]; andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP2K4 protein]; andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP2K6 protein]; andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP2K7 protein]; andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP3K5 protein]; andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAPK1 protein]; andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAPK3 protein]; andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of RAF1 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [andrographolide results in decreased expression of VEGFA mRNA]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [andrographolide results in decreased expression of VEGFA protein]; EGLN1 mutant form inhibits the reaction [andrographolide results in decreased expression of VEGFA protein]; pyrazolanthrone inhibits the reaction [andrographolide results in decreased expression of VEGFA mRNA]; pyrazolanthrone inhibits the reaction [andrographolide results in decreased expression of VEGFA protein] andrographolide results in decreased expression of VEGFA mRNA; andrographolide results in decreased expression of VEGFA protein |
CTD |
PMID:21134392 PMID:24814888 PMID:28651835 PMID:35724838 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vil1 |
villin 1 |
multiple interactions |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of VIL1 mRNA |
CTD |
PMID:19737545 |
|
NCBI chr 9:75,991,141...76,018,860
Ensembl chr 9:75,991,141...76,018,858
|
|
G |
Vim |
vimentin |
multiple interactions decreases expression |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of VIM mRNA; andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of VIM protein] andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of VIM protein]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of VIM protein]] andrographolide results in decreased expression of VIM protein |
CTD |
PMID:19737545 PMID:31128153 PMID:35917943 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
decreases expression |
ISO |
andrographolide results in decreased expression of XIAP protein |
CTD |
PMID:23845849 |
|
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|
G |
Zfand2a |
zinc finger AN1-type containing 2A |
decreases expression |
ISO |
andrographolide results in decreased expression of ZFAND2A mRNA |
CTD |
PMID:35724838 |
|
NCBI chr12:15,161,601...15,172,679
Ensembl chr12:15,161,639...15,172,677
|
|
G |
Zg16b |
zymogen granule protein 16B |
multiple interactions decreases expression |
ISO |
[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of SBPL mRNA andrographolide results in decreased expression of SBPL mRNA |
CTD |
PMID:19737545 |
|
NCBI chr10:12,970,888...12,984,170
Ensembl chr10:12,979,020...12,983,572
|
|